Real-time enrollment status for this neuroendocrine cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:40 AM UTC
| NCT Number | NCT05652686 |
| Recruiting Status | Recruiting |
| Condition | Neuroendocrine Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 203 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Phanes Therapeutics |
| Last Updated on CT.gov | July 9, 2026 (4 days ago) |
As of July 13, 2026: Clinical trial NCT05652686 is currently recruiting participants. This clinical trial study for neuroendocrine cancer is actively seeking new participants at 12 locations across the United States. The study is sponsored by Phanes Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05652686 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05652686 was last updated 4 days ago (July 9, 2026). HelloStudys verifies this status automatically.